Entering a new era of molecular classification of brain tumors: An update of 2021 World Health Organization classification in adult gliomas

被引:1
作者
Wang, Ching-Ying [1 ]
Lin, Shih-Chieh [2 ,3 ]
Chen, Ming-Teh [1 ,3 ]
Lee, Yi-Yen [3 ,4 ,5 ]
机构
[1] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Pathol &Lab Med, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Fac Med, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Neurol Inst, Div Pediat Neurosurg, Taipei, Taiwan
[5] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Div Pediat Neurosurg, 201 Sec 2, Shipai Rd, Taipei 11217, Taiwan
关键词
glioma; brain tumor; central nervous system; World Health Organization; CENTRAL-NERVOUS-SYSTEM; MUTATIONS; TP53;
D O I
10.1097/FS9.0000000000000031
中图分类号
R61 [外科手术学];
学科分类号
摘要
Glioma is the most common primary central nervous system tumor. The World Health Organization (WHO) 2021 classification of gliomas extended from WHO 2016 in the integration of molecular and histological classifications. WHO 2021 aims to establish a specific diagnosis that could reflect the biological and clinical features of the tumors, and further transform into more specific clinical studies or trials and therapeutics. Major updates of WHO 2021 classification focusing on glioma were reviewed in this article.
引用
收藏
页码:43 / 46
页数:4
相关论文
共 23 条
[1]   Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma [J].
Bell, Erica H. ;
Zhang, Peixin ;
Shaw, Edward G. ;
Buckner, Jan C. ;
Barger, Geoffrey R. ;
Bullard, Dennis E. ;
Mehta, Minesh P. ;
Gilbert, Mark R. ;
Brown, Paul D. ;
Stelzer, Keith J. ;
McElroy, Joseph P. ;
Fleming, Jessica I. ;
Timmers, Cynthia D. ;
Becker, Aline P. ;
Salavaggione, Andrea L. ;
Liu, Ziyan ;
Aldape, Kenneth ;
Brachman, David G. ;
Gertler, Stanley Z. ;
Murtha, Albert D. ;
Schultz, Christopher J. ;
Johnson, David ;
Laack, Nadia N. ;
Hunter, Grant K. ;
Crocker, Ian R. ;
Won, Minhee ;
Chakravarti, Arnab .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29) :3407-3417
[2]   cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas [J].
Brat, Daniel J. ;
Aldape, Kenneth ;
Colman, Howard ;
Figrarella-Branger, Dominique ;
Fuller, Gregory N. ;
Giannini, Caterina ;
Holland, Eric C. ;
Jenkins, Robert B. ;
Kleinschmidt-DeMasters, Bette ;
Komori, Takashi ;
Kros, Johan M. ;
Louis, David N. ;
McLean, Catriona ;
Perry, Arie ;
Reifenberger, Guido ;
Sarkar, Chitra ;
Stupp, Roger ;
van den Bent, Martin J. ;
von Deimling, Andreas ;
Weller, Michael .
ACTA NEUROPATHOLOGICA, 2020, 139 (03) :603-608
[3]   cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV" [J].
Brat, Daniel J. ;
Aldape, Kenneth ;
Colman, Howard ;
Holland, Eric C. ;
Louis, David N. ;
Jenkins, Robert B. ;
Kleinschmidt-DeMasters, B. K. ;
Perry, Arie ;
Reifenberger, Guido ;
Stupp, Roger ;
von Deimling, Andreas ;
Weller, Michael .
ACTA NEUROPATHOLOGICA, 2018, 136 (05) :805-810
[4]   Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas [J].
Brat, Daniel J. ;
Verhaak, Roel G. W. ;
Al-dape, Kenneth D. ;
Yung, W. K. Alfred ;
Salama, Sofie R. ;
Cooper, Lee A. D. ;
Rheinbay, Esther ;
Miller, C. Ryan ;
Vitucci, Mark ;
Morozova, Olena ;
Robertson, A. Gordon ;
Noushmehr, Houtan ;
Laird, Peter W. ;
Cherniack, Andrew D. ;
Akbani, Rehan ;
Huse, Jason T. ;
Ciriello, Giovanni ;
Poisson, Laila M. ;
Barnholtz-Sloan, Jill S. ;
Berger, Mitchel S. ;
Brennan, Cameron ;
Colen, Rivka R. ;
Colman, Howard ;
Flanders, Adam E. ;
Giannini, Caterina ;
Grifford, Mia ;
Iavarone, Antonio ;
Jain, Rajan ;
Joseph, Isaac ;
Kim, Jaegil ;
Kasaian, Katayoon ;
Mikkelsen, Tom ;
Murray, Bradley A. ;
O'Neill, Brian Patrick ;
Pachter, Lior ;
Parsons, Donald W. ;
Sougnez, Carrie ;
Sulman, Erik P. ;
Vandenberg, Scott R. ;
Van Meir, Erwin G. ;
von Deimling, Andreas ;
Zhang, Hailei ;
Crain, Daniel ;
Lau, Kevin ;
Mallery, David ;
Morris, Scott ;
Paulauskis, Joseph ;
Penny, Robert ;
Shelton, Troy ;
Sherman, Mark .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) :2481-2498
[5]   Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 [J].
Cairncross, Gregory ;
Wang, Meihua ;
Shaw, Edward ;
Jenkins, Robert ;
Brachman, David ;
Buckner, Jan ;
Fink, Karen ;
Souhami, Luis ;
Laperriere, Normand ;
Curran, Walter ;
Mehta, Minesh .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :337-343
[6]   Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].
Cairncross, JG ;
Ueki, K ;
Zlatescu, MC ;
Lisle, DK ;
Finkelstein, DM ;
Hammond, RR ;
Silver, JS ;
Stark, PC ;
Macdonald, DR ;
Ino, Y ;
Ramsay, DA ;
Louis, DN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479
[7]  
Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO
[8]  
2-W
[9]   TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas [J].
Gillet, Emeline ;
Alentorn, Agusti ;
Doukoure, Brahima ;
Mundwiller, Emeline ;
van Thuij, Hinke ;
Reijneveld, Jaap C. ;
Medina, Jose Alfonso Meza ;
Liou, Amelie ;
Marie, Yannick ;
Mokhtari, Karima ;
Hoang-Xuan, Khe ;
Sanson, Marc ;
Delattre, Jean-Yves ;
Idbaih, Ahmed .
JOURNAL OF NEURO-ONCOLOGY, 2014, 118 (01) :131-139
[10]  
Han CH, 2017, CHIN CLIN ONCOL, V6, DOI 10.21037/cco.2017.06.11